Cost analysis of recall strategies for non-invasive diagnosis of small hepatocellular carcinoma

Digestive and Liver Disease

Volumn 42, Issue 10, 2010, Pages 729-734

  Piscaglia, Fabio ^a   Leoni, Simona ^a   Cabibbo, Giuseppe ^b   Borghi, Alberto ^a   Imbriaco, Grazia ^a   Golfieri, Rita ^c   Bolondi, Luigi ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Contrast enhanced imaging techniques; Cost effectiveness; Hepatocellular carcinoma; Recall strategy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SIZE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; COST BENEFIT ANALYSIS; EARLY CANCER; ECHOGRAPHY; FEMALE; HUMAN; IMAGING; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER NODULE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; COSTS AND COST ANALYSIS; DIAGNOSTIC IMAGING; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 77956291315     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2010.03.003     Document Type: Article

References (21)

1. Bruix J., Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42(5 (November)):1208-1236.
2. El-Serag H.B. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004, 127(5 Suppl. 1 (November)):S27-34.
3. Bugianesi E., Leone N., Vanni E., et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002 Jul, 123(1):134-140.
4. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996 Mar 14, 334(11):693-699.
5. Sala M., Fuster J., Llovet J.M., et al. High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation. Liver Transpl 2004 Oct, 10(10):1294-1300.
6. Cucchetti A., Ercolani G., Vivarelli M., et al. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl 2006 Jun, 12(6):966-971.
7. Tateishi R., Shiina S., Teratani T., et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005, 103(6 (March 15)):1201-1209.
8. Livraghi T., Meloni F., Di Stasi M., et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice?. Hepatology 2008 Jan 1, 47(1):82-89.
9. Livraghi T., Bolondi L., Lazzaroni S., et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients. Cancer 1992, 69(4 (February 15)):925-929.
10. Terminology of nodular hepatocellular lesions. International Working Party. Hepatology 1995 Sep, 22(3):983-993.
11. Tomemori T., Yamakado K., Nakatsuka A., et al. Fast 3D dynamic MR imaging of the liver with MR SmartPrep: comparison with helical CT in detecting hypervascular hepatocellular carcinoma. Clin Imaging 2001, 25(5):355-361.
12. Ward J., Guthrie J.A., Scott D.J., et al. Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis. Radiology 2000 Jul, 216(1):154-162.
13. Gaiani S., Celli N., Piscaglia F., et al. Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. J Hepatol 2004 Sep, 41(3):421-426.
14. Quaia E., Calliada F., Bertolotto M., et al. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 2004 Aug, 232(2):420-430.
15. Nicolau C., Catala V., Vilana R., et al. Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol 2004 Jun, 14(6):1092-1099.
16. Leoni S., Piscaglia F., Golfieri R., et al. The Impact of Vascular and Nonvascular Findings on the Noninvasive Diagnosis of Small Hepatocellular Carcinoma Based on the EASL and AASLD Criteria. Am J Gastroenterol 2009, (November 24).
17. Albrecht T., Blomley M., Bolondi L., et al. Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall Med 2004, 25(4 (August)):249-256.
18. Thompson Coon J., Rogers G., Hewson P., et al. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis. Health Technol Assess 2007 Sep, 11(34):1-206.
19. Forner A., Vilana R., Ayuso C., et al. Diagnosis of hepatic nodules 20mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 2008 Jan, 47(1):97-104.
20. Bolondi L., Gaiani S., Celli N., et al. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 2005 Jul, 42(1):27-34.
21. Sangiovanni A., Manini M.A., Iavarone M., et al. The diagnostic and economic impact of contrast imaging technique in the diagnosis of small hepatocellular carcinoma in cirrhosis. Gut 2009, (December 1).